Dihydropyridines as potent calcium channel blockers in neuronal cells  by Takahashi, Masami & Ogura, Akihiko
Volume 152, number 2 FEBS LETTERS February 1983 
~ihydru~y~~d~~es as potent calcium channel blockers in neuronal 
cells 
Masami Takahashi and Akihika Ogura 
Laboratory of neurochemistry, ~~fs~~ish~-Kase~ rnstitute of Life Sciences, ~ach~~a-shy, Tokyo 194, Japan 
Received 10 October 1982; revision received 14 December I982 
N~card~p~ne, o e of the dihydropyridiae derivatives, in a nanomolar concentration range suppressed the 
high K-induced neurotransmitte~ release from cultured neuronal cells (chick embryonic neural retina ceils 
and clonal rat pheochromocytoma cells). The high K’-induced Ca2* uptake into pheochromocytoma cell 
was also blocked by nicardipine in the same concentration range. 13H]Nitrendipine, another 
dihydropyridine derivative, bound specifically to pheochromocytoma cell homogenate in a saturable 
manner. We concluded that dihydropyridines block and bind to the high K*-sensitive Ca*+ channels in 
neuronal cells. 
Calcium ions play important roles in regulating 
various neuronal functions, among which are 
membrane excitation [ 11, neurotransmitter release 
[2] and protein phosphorylation [3,43. Voltage- 
sensitive Ca2+ channels are one of the key factors 
determining the cellular Ca2+ level. The Ca2+ anta- 
gonists that block the voltage-sensitive Ca2’ chan- 
nels of neuronal cells in a nanomolar concentra- 
tion range are so far not known [S]. Those drugs 
are longed for not onfy in physiological studies to 
suppress the Ca” channel-mediated functions with 
minimum interference with other ion channels but 
in biochemical and morphological experiments to 
identify the Ca2’ channels. 
We report here that 1,4_dihydropyridine deriva- 
tives, known as Ca2’ channel blockers in heart and 
smooth muscle tissues [6], block the high 
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aminobutyric acid; Hepes, ~-2-hydro~yeihyl~~peraz~ne 
N’ -2-ethanesulfonic acid; NE, norepinephrine; Tris, tris 
~ydroxymei~y~~ aminometh~e 
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K+-induced Ca” uptake into and transmitter re- 
lease from the cultured neuronal cells in the nano- 
molar range.. These blockades suggest hat dihy- 
dropyridine inhibits the function of the neuronal 
voltage-sensitive Ca2+ channel. A radioactive deri- 
vative of dihydropyridine bound to the neuronal 
cell and thus may serve as a molecular probe for 
the neuronal Cazf channel. 
2. MATERIALS AND METHODS 
Neural retina cells were isolated from g-day 
:hick embryos. After diss~iation with trypsin, 2 x 
i06 cells were plated on poly-D-lysine-coated 
35 mm plastic dish (Falcon). The culture was 
maintained for 6 days in DMEM containing 5% 
newborn calf serum. Rat pheochromocytoma clo- 
ne PC12 cells [7] (subclone h [8] was used) were 
plated on poly-D-lysine-coated 35 mm plastic dish 
(IO6 cells/dish) and maintained for 2 days in 
DMEM containing 5% newborn calf serum and 
5% heat-inactivated horse serum. Assays for high 
K+-induced transmitter release and Ca2* uptake 
were made as described in 191. See figure legends 
for brief descriptions, The high Kt-stimulation 
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was performed by an elevation of external 
K+-concentration. Hypertonicity was not compen- 
sated, since preliminary experiments employing the 
hypertonic high K+ solution and isotonic high K+ 
(NaCl-subtracted) solution did not show the differ- 
ence in the amount and time-course of transmitter 
release. For the radioligand binding assay, PC12 
cells were disrupted by sonication in 50 mM 
Tris-HCl (pH 7.3) buffer and the homogenate 
(0.47 mg protein) was incubated in the_ 2 ml buffer 
containing [3HJnitrendipine for 75 min at 25°C. 
Binding was terminated by a rapid vacuum filtra- 
tion over a Whatman GFlB filter followed by seve- 
ral rinses with ice-cold buffer. The filter was coun- 
ted for radioactivity. Specific binding was defined 
as that displaced by coincubation with low6 M ni- 
cardipine. Preliminary experiments revealed that 
the binding was linear in the range of O-O.5 mg 
protein. The binding saturated over 45 min. 
All experiments with dihydropyridine derivati- 
ves were done under darkness or dimmed light. 
Protein was determined after Lowry et al. [IO] with 
bovine serum albumin as the standard. 
The following materials were obtained from the 
companies indicated: 45CaC12 (spec. act. 32 Ci/g 
Ca) and 13H]GABA (57 Ci/mmol), Amersham; 
[3H]nitrendipine (88 Ci/mmol) and [3H]norepi- 
nephrine (46.5 Ci/mmol), New England Nuclear; 
Hepes and poly-D-lysine, Sigma; DMEM and 
horse serum, Gibco; precolostrum newborn calf 
serum, Mitsubishi Chemical Ind. Ltd., Tokyo; 
nicardipine [ll], gift from Yamanouchi Pharma- 
ceutical Co., Tokyo. 
3. RESULTS AND DISCUSSION 
The cultured chick embryonic neural retina cells 
released the preloaded [3H]GABA by an elevation 
of external Kf concentration from 5.4 to 51.4 mM 
as reported in [12]. As shown in fig.1, nicardipine 
markedly suppressed the high K+-induced 
[3H]GABA release in a dose-dependent manner. 
The threshold of the inhibition was lo-’ M and 
60% of the release was suppressed at lo-’ M. Ni- 
cardipine did not affect to the basal release seen 
under low K+ conditions. 
To eliminate the difficulties in interpretation of 
experimental results due to the presence of non- 
neuronal cells and the heterogeneity among neuro- 
nes in the cultured neural tissues, we used for fur- 
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Fig. 1. Dose-dependent i hibition of high K+-induced 
[3H]GABA release from cultured neural retina cells by 
nicardipine. The assay was made as follows: The cell was 
exposed for 1 h to the balanced salt solution (BSS, 
composed of 130 mM NaCI, 5.4 mM KCI, 1.8 mM 
CaC12,0.8 mM MgS04,5.5 mM glucose, 50 mM Hepes- 
NaOH pH 7.3) supplemented with [‘H]GABA 
(0.5 &X/dish). After another incubation with BSS 
containing no t3H]GABA for 1 h, BSS was replaced 5 
times at 1 min intervals. At the 5th replacement, BSS 
was strengthened with KC1 (51.4 mM in final cont.). 
Nicardipine was included at the 3rd replacement and 
thereafter. The release was expressed by a percentage of 
the radioactivity of the 5th replacement o that of the 
cells solubilized after the experiment (0). For the release 
under low KCI, the ratio of the 4th replacement o the 
cel1 Iysate was plotted (0). The value plotted represents 
each one experimental point. The total [3H]GABA 
uptaken in the ceI1 prior to the release was 81021 + 
3644 cpmldish. 
ther analyses a rat pheochromocytoma clone 
PC12, which shares many cellular properties with 
sympathetic neurones [7,8,13-151. Figure 2 shows 
the inhibition of high K+-induced [3H]NE release 
from PC12 cells by nicardipine. The inhibition was 
dose-dependent and complete at lo-’ M. The dose 
of half inhibition was about 7 x IO-’ M, 
In the presence of 1 mM CaCl2, the high 
K+-induced [3H]NE release from PC12 cells was 
inhibited by 69% with lo-* M nicardipine (070 re- 
leases over 1 min were 3.6 and 5.2 with and 
without nicardipine, respectively). When CaClz 
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Fig.2. Dose-dependent inhibition of high K+-induced 
[3H]NE release from PC12 cells by nicardipine. The 
assay method was the same as in fig.1 but for t3H]NE 
(0.25 &i/dish) instead of [3H]GABA. Ascorbic acid 
(1.2 mM) was added to BSS. Releases under 5.4 and 
5 1.4 mM KC1 were indicated by o and l , respectively. 
The value plotted represents each one experimental 
point. The total [3H]NE uptaken in the cell prior to 
release was 21430 + 717 cpm/dish. 
was raised to 3 mM, the release was inhibited by 
37% with 10V8 M nicardipine (Ore releases were 2.3 
and 3.6 with and without nicardipine, respective- 
ly). Such antagonistic effect of external Ca2+ is 
common to the known Ca2+ channel blockers [6]. 
Exposure to high K+ environment causes Ca” 
uptake into PC12 cells through direct activation of 
the voltage-sensitive Ca*+ channels [161. Nicardipi- 
ne inhibited the high K+-induced Ca2+ uptake into 
PC12 cells in a dose-dependent manner (fig.3). The 
dose of half inhibition was about 2 x lo-* M. 
These results suggest that nicardipine blocked 
the function of the high K+-sensitive (probably 
identical to the so-called voltage-sensitive) Ca2+ 
channel of neural cells. This was also indicated by 
an observation that [3H]NE release induced by 
maitotoxin, a dinoflagellate toxin considered to di- 
rectly activate the Ca2+ channels [9], was blocked 
by nicardipine (not shown here). 
Recent reports showed that [3H]nitrendipine, 
another dihydropyridine derivative, specifically 
bound to the membrane fractions from rat brain 
1-t 
1-1 
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Fig.3. Dose-dependent inhibition of high K+-induced 
Ca*+ uptake into PC12 cells by nicardipine. After 
replacement of the culture medium with BSS, the cells 
were exposed to BSS containing nicardipine of indicated 
concentration for 2 min. Then, the solution was 
replaced with BSS containing nicardipine. 45CaC12 
(1 &i/dish) and KC1 (0, 51.4 mM; 0, 5.4 mM, in final 
cont.). After 30 s exposure to the 45Ca-containing BSS, 
the cells were rinsed thoroughly four times with ice-cold 
BSS. Finally the cells were alkali-solubilized and 
radioactivity was counted. Preliminary experiments 
showed that the uptake increased linearly with time up 
to 40 s. Means + SD from 4 successive xperiments were 
shown after standardization. The mean value of Ca’+ 
uptake in 51.4 mM KC1 without nicardipine (2.55 + 
0.68 nmol/mg protein/30 s) was taken as 100%. 
[17-201. It is not clear whether those [3H]nitrendi- 
pine bindings were of neuronal origin, since brain 
contains non-neuronal cells as glia and blood ves- 
sels. We found that [3H]nitrendipine specifically 
bound to PC12 cell homogenate in a saturable 
manner (fig.4). Scatchard plot revealed the dissoci- 
ation constant (KD) of 1.5 x lo-” M and the maxi- 
mal binding capacity (B,,,) of 6.5 fmol/mg pro- 
tein. In comparison with brain homogenates (Kp, 
0 9-l 6 x 10-r’ M and B . . max, 4-15 fmol/mg wet 
tissue weight [ 17-201, PC12 cells had similar KD 
and smaller B,,,. 
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Fig.4. (A) Binding of [3H]nitrendipine to PC12 cell 
homogenate as a function of concentration of added 
nitrendipine. Points were determined in triplicate and 
non-specific binding was determined in parallel samples 
which contained 10m6 M nicardipine (0, total binding; 
0, non-specific binding). (B) Scatchard plot of specific 
[3H]nitrendipine binding to PC12 cell homogenate based 
on data in A. 
From these results, dihydropyridine derivatives 
can be useful chemical tools for the study of Ca’+ 
channel of neurones. 
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NOTE ADDED IN PROOF 
After submission of this manuscript, a report 
with conclusions qualitatively the same as ours was 
published [L. Toll. (1982) J. Biol. Chem. 257, 
13189-131921. 
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